Section 2, Surrogacy (Regulation) Act, 2021 [S2A-7V2]
As at 7 September 2026. In force from 18 April 2021 by S.O. 1509(E) [N12-KWG].
2. Definitions.—In this Act, unless the context otherwise requires,— (a) "drug" includes all medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals; (b) "Licensing Authority" means the authority appointed under section 4 to grant licences under this Act; (c) "registered medical practitioner" means a person who is registered in a State Medical Register or the Indian Medical Register; (d) "manufacture" in relation to any drug, includes any process or part of a process for making, altering, ornamenting, finishing, packing, labelling, breaking up or otherwise treating or adopting any drug with a view to its sale or distribution; (e) "notification" means a notification published in the Official Gazette, and the expression "notified" shall be construed accordingly; (f) "prescribed" means prescribed by rules made under this Act.
Defined terms in this text (4)
drug: Section 2, Surrogacy (Regulation) Act, 2021 [S2A7V2] (In this Act, unless the context otherwise requires,—): "drug" includes all medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals
drug: 19 more definitions.
Licensing Authority: Section 2, Surrogacy (Regulation) Act, 2021 [S2A7V2] (In this Act, unless the context otherwise requires,—): "Licensing Authority" means the authority appointed under section 4 to grant licences under this Act
Licensing Authority: 21 more definitions.
manufacture: Section 2, Surrogacy (Regulation) Act, 2021 [S2A7V2] (In this Act, unless the context otherwise requires,—): "manufacture" in relation to any drug, includes any process or part of a process for making, altering, ornamenting, finishing, packing, labelling, breaking up or otherwise treating or adopting any drug with a view to its sale or distribution
manufacture: 36 more definitions.
registered medical practitioner: Section 2, Surrogacy (Regulation) Act, 2021 [S2A7V2] (In this Act, unless the context otherwise requires,—): "registered medical practitioner" means a person who is registered in a State Medical Register or the Indian Medical Register
registered medical practitioner: 20 more definitions.
Made under this section, or naming it (0)
none
Cited by (1)
Rule 2, Surrogacy (Regulation) Act Rules, 2023 [S2B-904], 3 January 2023, Band A. " (2) Words and expressions used herein and not defined but defined in the Act shall have the meanings respectively assigned to them in the Act".
Not held (0)
none
Duties published under this section (0)
none